MedPath

The Blended Care Intervention "Booster" for Youth With Chronic Health Conditions to Increase Fatigue-related Self-efficacy

Not Applicable
Not yet recruiting
Conditions
Chronic Illnesses
Fatigue
Interventions
Other: Booster
Registration Number
NCT06562335
Lead Sponsor
UMC Utrecht
Brief Summary

The goal of this experimental study is to learn if the Booster intervention can be used as an early intervention for persistent fatigue. The aim of the intervention is to prevent more fatigue-related disabilities in young people with chronic illnesses like inflammatory bowel disease, childhood cancer, and juvenile idiopathic arthritis by improving self-confidence in managing fatigue (fatigue-related self-efficacy or FSE).

The main questions this study aims to answer are:

* What is the effect of the Booster intervention on fatigue-related self-efficacy (FSE)?

* What is the effect of the Booster intervention on fatigue levels, school participation, life satisfaction, and perceived health?

* When does improvement in study outcomes happen relative to the Booster intervention?

* What participant characteristics predict change in study outcomes?

Participants will follow the Booster intervention. Booster is a personalised, blended care intervention designed to help young people understand how their thoughts, feelings, and activities impact their fatigue using a smartphone app. The Booster app uses experience sampling methodology (ESM) to track these fluctuations. Based on insights obtained from these data, the participant and their healthcare provider can set personal lifestyle goals, such as increasing physical activity and reducing daytime naps. An earlier version of this intervention, called PROfeel, was effective in reducing severe fatigue. The investigators have now improved the app to also help with setting and achieving personal goals and monitoring daily progress.

The investigators will measure the effect of Booster through daily questionnaires during two phases: Phase A (baseline, before the goal setting between patient and healthcare provider) and Phase B (intervention, starting in the lifestyle change period). The duration of Phase A will be randomised for each participant.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Experiencing fatigue for at least 3 months and feeling hindered by it (Pediatric Short Fatigue Questionnaire (pSFQ) score of 15 or higher)
  • Diagnosed with a chronic health condition or treated for childhood cancer
Exclusion Criteria

Regarding other treatments:

  • Fatigue fully explained by a somatic or psychiatric diagnosis
  • Chronic health condition unstable in the last 3 months (e.g., recent medication changes or cancer relapse)
  • Significant functional limitations due to fatigue (e.g., more than 50% school absenteeism)

Regarding feasibility:

  • Cognitive impairment with an estimated IQ of below 70
  • No smartphone with internet access
  • Unable to speak, read, understand, or write Dutch

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Booster interventionBooster* Start conversation: participant personalises the Booster app, supported by the Booster practitioner * Measurement period: the participant fills out short repeated questionnaires 5 times daily for 4 weeks in the Booster app. This method is called experience sampling methodology (ESM). Questions are partially personalised to reflect factors that the participants believes are related to fatigue. Questions cover thoughts, feelings, and activities. * Insight conversation: the Booster practitioner discusses the analysed questionnaires with the participant. Together they set lifestyle goals based on the insight obtained. * Experiment period: the participant works on the lifestyle goals supported by the goal attainment module in the Booster app.
Primary Outcome Measures
NameTimeMethod
Fatigue-related self-efficacyDaily before and during the intervention, for approximately 130 days

Single-item question, self-report via Booster app. The single item was designed and validated for this study. Answered on a VAS scale 0 to 100. Higher score represents higher fatigue-related self-efficacy.

Secondary Outcome Measures
NameTimeMethod
ParticipationDaily before and during the intervention, for approximately 130 days

School or work presence. Calculated: (hours present/the hours scheduled)\*100

Fatigue severityDaily before and during the intervention, for approximately 130 days

pediatric short fatigue questionnaire, 4-item questionnaire, answered on a seven point Likert scale (1 = yes that is true, 7=no, that is not true). Total score ranges from 4 to 28, with higher scores reflecting more fatigue.

Perceived healthDaily before and during the intervention, for approximately 130 days

EuroQol (EQ) visual analogue scale (VAS), ranging from 0 (worst health you can imagine) to 100 (best health you can imagine).

Life satisfactionDaily before and during the intervention, for approximately 130 days

Cantril Ladder, single-item question, rate life with ladder numbered from 0 to 10. Top of the ladder (10) represents the best possible life. The bottom (0) represents the worst possible life.

Trial Locations

Locations (1)

Wilhelmina Children's Hospital, University Medical Centre Utrecht

🇳🇱

Utrecht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath